Covaxin trials a 2-dose schedule: Bharat Biotech on Vij testing positive

Hours after Haryana Health Minister Anil Vij, who was administered a dose of Covaxin last month, tested positive for Covid-19, Hyderabad-based Bharat Biotech said that the efficacy of its Covid-19 vaccine could be determined only fourteen days after a second dose.

The clarification came alongside the Union Health Ministry’s clarification, after Vij tested positive days after being given one shot of the vaccine, which is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research, at a hospital in Ambala.

Vij was administered the first dose on November 20 as part of the third phase of the trial after the Haryana Minister had volunteered. It is early days to gauge the effect on Vij as the outcome is measured after 14 days of the second dose administered.

“Covaxin clinical trials are based on a 2-dose schedule, given 28 days apart. The vaccine efficacy will be determined 14 days post the 2nd dose. Covaxin has been designed to be efficacious when subjects receive both doses and post the 14 days period after the 2nd dose,” the company said in a statement.

Read More: https://www.bhaskarlive.in/covaxin-trials-a-2-dose-schedule-bharat-biotech-on-vij-testing-positive/